SEC Form 4 · accession 0001209191-15-080389
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Lo
Officer — SVP Oncology
Period of report
Nov 16, 2015
Accepted (ET)
Nov 16, 2015 · 6:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Nov 16, 2015 | M | 113,960 | $3.51 | A | 113,960 | D | |
| Common stockF1 | Nov 16, 2015 | M | 286,040 | $3.51 | A | 400,000 | D | |
| Common stockF1 | Nov 16, 2015 | M | 33,333 | $2.70 | A | 433,333 | D | |
| Common stockF1 | Nov 16, 2015 | M | 64,583 | $2.075 | A | 497,916 | D | |
| Common stockF1 | Nov 16, 2015 | M | 87,500 | $1.92 | A | 585,416 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock optionF2 | $3.51 | Nov 16, 2015 | M | 113,960 | A | — | Sep 23, 2020 | Common stock | 113,960 | 0 | D |
| Stock optionF2 | $3.51 | Nov 16, 2015 | M | 286,040 | A | — | Sep 23, 2020 | Common stock | 286,040 | 0 | D |
| Stock optionF2 | $2.70 | Nov 16, 2015 | M | 33,333 | A | — | Oct 9, 2022 | Common stock | 33,333 | 0 | D |
| Stock optionF2 | $2.075 | Nov 16, 2015 | M | 64,583 | A | — | Jan 29, 2023 | Common stock | 64,583 | 0 | D |
| Stock optionF2 | $1.92 | Nov 16, 2015 | M | 87,500 | A | — | Nov 18, 2023 | Common stock | 87,500 | 0 | D |
Explanation of responses
- F1Exercise and hold.
- F2Fully exerciseable.